Delaet Ingrid sold NBIX
February 3, 2025 · Form 4 insider transaction
Delaet Ingrid sold 623 shares of Neurocrine Biosciences, Inc. at $149.29 per share, a transaction worth $93.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
623
Price
$149.29
Total value
$93.0K
InsiderDelaet Ingrid
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 3, 2025
Filing dateFebruary 4, 2025
Shares owned after3,442
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2022. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.